ARCHIVES

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

November issue of Business & Regulatory Report included.

November 28, 2003

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

September 7, 2012

In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI

October 1, 1999

Phase II Study of Veliparib Improves PFS by 35 Percent

October 31, 2014

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997